In the specialized field of biochemical re RGD sequence characterizes sites for integrin-mediated cell adhesion. Plow, EF; et al., Proc. Natl. Acad. Sci. USA, 82, 8057 (1985); Brake, DA; et al., search, the RGDS peptide—a tetrapeptide sequence consisting of Arginyl-glycyl-aspartyl-serine (Arg-Gly-Asp-Ser)—serves as a critical tool for studying cellular interactions. As someone who has spent considerable time exploring laboratory-grade biochemical reagents, I have found that understanding the specific interplay between synthetic peptides and cell RGD Peptides: Integrin Binding Motifs for Cell Adhesion ular matrices is essential for any rigorous investigative work.
The Biochemical Profile of RGDS
At its core, the peptide RGDS is recognized as a synthetic cell adhesion factor. It functions primarily as an integrin-binding sequence. In many experimental models, RGDS is utilized because it acts as an inhibitor of integrin receptor function. By mimicking the cell attachment site found in proteins like fibronectin, this tetra-peptide allows researchers to modulate how cells inte RGD peptide (7723) by Tocris, Part of Bio-Techne ract with RGD peptide (Arg-Gly-Asp) | Tripeptide | CAS 99896-85-2 their surrounding environment.
From a structural perspective, the RGDS peptide (CAS 91037-65-9) has a molecular weight of approximately 433.42 Da. When sourcing this material for laboratory use, purity is paramount; high-quality samples typically exhi RGD Peptides: Integrin Binding Motifs for Cell Adhesion bit a purity of >95%, often confirmed via NMR and HPLC analysis. It is important to reiterate that this is a laboratory product for research use only and is strictly not for personal consumption.
Mechanisms and Research Applications
The scientific literature frequently highlights that RGDS peptide is a fibronectin inhibitor. Because it is an inhibitor of the binding of integrins to the extracellular matrix (ECM), it serves as a powerful instrument for dissecting signaling pathways.
Some of the most compelling research involves its use in:
* Integrin-Mediated Signaling: RGD peptides are used to study cell adhesion mechanisms and integrin signaling pathways, providing a window into how cells sense their mechanical environment.
* Targeting and Modulation: Research has shown that RGD peptides can be utilized to specifically target cancer cells and tumor vasculature by engaging with specific integrins. Furthermore, studies have demonstrated that RGDS inhibits melanoma growth through an adhesion-independent mechanism, potentially by interacting with intracellular survivin.
* RGDS peptide is a tetrapeptide found on fibronectin, fibrinogen α, and von Willebrand factor, but not vitronectin or collagen. Inflammatory Response Studies: In specific pulmonary models, a synthetic RGDS peptide can b Peptite-2000™ RGD Peptide #5462 e used to inhibit pulmonary i RGD. This is fibronectin derived, integrin-binding peptide. It may be used for PEG hydrogel preparation. nflammatory responses by mitigating the effects of lipopolysaccharides (LPS).
Understanding the RGD Motif
While the RGDS tetrapeptide is specific, it is part of a broader family of RGD ( RGDS peptide, Fibronectin inhibitor MW 433.42 Da, Purity >95%. Achieve your results faster with highly validated, pure and trusted compounds. Chemical Arg-Gly-Asp) peptides. The RGD motif is a cell adhesion sequence that binds to integrins, which are a receptor family for extracellular matrix proteins. Whether working with a simple tripeptide or a more complex RGD-containing peptide, the goal is often the same: to bridge inert laboratory materials with ECM-like functionality.
For instance, some variants are designed to include a thiol group on the N-terminus, allowing the peptide to be immobilized on thiol-reactive polymers. This is particularly useful in hydrogel preparation and tissue engineering, where directing the association of various cell types with diverse biomaterials is a primary objective.
Essential Considerations for Researchers
When integrating these compounds into your studies, it is vital to keep the following in mind:
1. Specificity: Always distinguish between the shorter RGD sequences and the specific RGDS tetrapeptide. Their inhibitory profiles against various ligands—such as fibrinogen, von Willebrand factor, and fibronectin—can differ significantly.
2. Experimental Control: Because Arg-Gly-Asp-Ser is an integrin-binding sequence that inhibits integrin receptor function, it is essential to use appropriate negative controls to ensure that observed effects are truly due to the interruption of cell-matrix signaling.
3. Safety and Handling: Always treat these substances as professional reagents. They are fibronectin-derived, integrin-binding peptides meant for controlled environments. Any suggestion of personal use is both scientifically unfounded and dangerous; these compounds are strictly for *in vitro* or *in vivo* animal research models.
By maintaining high standards of reagent purity and focusing on the well-documented mechanisms of the RGD sequence (which characterizes sites for integrin-mediated cell adhesion), researchers can continue to unlock the complexities of cell biology. The RGDS peptide remains a foundational tool in this pursuit, offering a reliable way to mimic and modulate the natural signals that govern cellular behavior.